Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Pfizer, Lilly and Bayer fined for price-fixing in Switzerland
January 2010
SHARING OPTIONS:

BERN, Switzerland—The Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of $5.7 million by competition regulators on Dec. 1 for alleged price-fixing of drugs for erectile dysfunction. The Swiss Competition Commission contends that the prices for Viagra (sildenafil), Cialis (tadalafil) and Levitra (vardenafil) were fixed via public price recommendations. The commission didn't say how much each company was fined, and declined to provide the information. The commission concluded in February, after a lengthy investigation that began in June 2006, that the firms made "inadmissible vertical competition agreements" by maintaining a recommended public selling price for the drugs. The three companies rejected the allegations.                  

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.